header logo image


Page 8«..78910..»

Archive for the ‘Opthalmology’ Category

Omaha eye surgeon travels the world to offer vision and hope – KETV Omaha

Tuesday, February 18th, 2020

In a couple weeks, he'll go to South America. A few months ago, he traveled to India and this summer he will return. Omaha eye surgeon, Dr. Donny Suh, (pronounced "saw"), is no stranger to volunteer mission trips, first traveling to offer his expertise and services more than 20 years ago with the vising saving organization, Orbis. "I feel very honored and privileged," said Suh, who took a moment from his work as Chief of Pediatric Opthalmology at Children's Hospital and Medical Center, to talk about his volunteer work. Suh also teaches at the University of Nebraska Medical Center and he see patients at Nebraska Medicine where he tackles the most challenging eye issues. He recently returned from a trip to Bihar State, India, where he helped with hospital based training doing cataract surgeries on children. Suh supervised 18 surgeries with trained Indian doctors, showing them how to use the latest surgical equipment provided by the non-profit, Orbis. "This place was particularly advanced. But they were using equipment that was 20 to 30 years old," he said.Surgeons in that hospital perform about 300 surgeries a day. Orbis has 400 volunteer faculty worldwide from more than 30 countries working to prevent blindness around the globe. In Omaha, Suh said he might see two or three children per week with cataracts. About a billion people worldwide have a vision issue that could be prevented or hasn't been addressed. Suh said pediatric cataracts are very common in India because of malnutrition, poor prenatal care and a lack of immunizations. Cataracts make the lens of the eye more opaque, blocking light and causing blindness. "We were in the poorest part of India where everyone lives day to day," said Suh. He said the team of doctors and nurses worked out of an inspiring eye hospital which served multiple purposes. He said the man who built Akhand Jyoti Hospital/School saw the need to serve some of the poorest people on Earth, but also he built it as an educational opportunity to hire girls to work there, train, study, play soccer, and become optometrists."He saw that a lot of girls were being married as teenagers and wanted more for them," said Suh. He said more than 500 young women are now working as eye doctors. Suh often talks about the role vision plays in all aspects of life, especially for a growing child."Vision is responsible for 75 to 85-percent of development. Sight is not just sight. It gives people hope," said Suh. He said he's seen multiple children over the years who couldn't even take their first steps until they were able to see others walk and model the behavior."They would get up and walk the very next day after surgery," he said.KETV has reported on Suh in the past, featuring his efforts to bring vision screenings, training, and an eye clinic to Guatemala. The South Korea native who grew up in dire poverty with his brother and single mom said it's his mission to give back to others, especially in third-world countries. In his recent book, "Catching a Star: My Story of Hope", Suh talks about his childhood, his desire to help others, and life-changing encounters with patients.He writes about a mother who gave birth to a child with multiple genetic and health challenges including a lack of clear vision because of cataracts. Doctors said the baby had just months to live. Suh said the mother begged him to do eye surgery on the child so that when her baby met her in heaven one day, the child would recognize her face. Suh said he was deeply moved by the mother's request and told her, "I will give you my 100-percent so that the baby can see you after surgery."He said, the next day, the baby couldn't stop staring at the mother's face. The child is now 3 and a half years old. "It's truly incredible," said Suh. He believes vision played a large part in helping the child to live. All proceeds from the sale of Suh's book will go toward medical missions and helping children to see. His book is available on Amazon.

In a couple weeks, he'll go to South America. A few months ago, he traveled to India and this summer he will return. Omaha eye surgeon, Dr. Donny Suh, (pronounced "saw"), is no stranger to volunteer mission trips, first traveling to offer his expertise and services more than 20 years ago with the vising saving organization, Orbis.

"I feel very honored and privileged," said Suh, who took a moment from his work as Chief of Pediatric Opthalmology at Children's Hospital and Medical Center, to talk about his volunteer work. Suh also teaches at the University of Nebraska Medical Center and he see patients at Nebraska Medicine where he tackles the most challenging eye issues.

Dr. Suh takes pride in helping to train eye surgeons with the latest technology.

He recently returned from a trip to Bihar State, India, where he helped with hospital based training doing cataract surgeries on children. Suh supervised 18 surgeries with trained Indian doctors, showing them how to use the latest surgical equipment provided by the non-profit, Orbis.

"This place was particularly advanced. But they were using equipment that was 20 to 30 years old," he said.

Surgeons in that hospital perform about 300 surgeries a day.

Orbis has 400 volunteer faculty worldwide from more than 30 countries working to prevent blindness around the globe.

In Omaha, Suh said he might see two or three children per week with cataracts.

About a billion people worldwide have a vision issue that could be prevented or hasn't been addressed.

Dr. Donny Suh has volunteered on mission trips for 20 years.

Suh said pediatric cataracts are very common in India because of malnutrition, poor prenatal care and a lack of immunizations. Cataracts make the lens of the eye more opaque, blocking light and causing blindness.

"We were in the poorest part of India where everyone lives day to day," said Suh. He said the team of doctors and nurses worked out of an inspiring eye hospital which served multiple purposes. He said the man who built Akhand Jyoti Hospital/School saw the need to serve some of the poorest people on Earth, but also he built it as an educational opportunity to hire girls to work there, train, study, play soccer, and become optometrists.

"He saw that a lot of girls were being married as teenagers and wanted more for them," said Suh. He said more than 500 young women are now working as eye doctors.

Suh often talks about the role vision plays in all aspects of life, especially for a growing child.

"Vision is responsible for 75 to 85-percent of development. Sight is not just sight. It gives people hope," said Suh.

He said he's seen multiple children over the years who couldn't even take their first steps until they were able to see others walk and model the behavior.

"They would get up and walk the very next day after surgery," he said.

KETV has reported on Suh in the past, featuring his efforts to bring vision screenings, training, and an eye clinic to Guatemala.

The South Korea native who grew up in dire poverty with his brother and single mom said it's his mission to give back to others, especially in third-world countries.

Suh and his brother were born in South Korea.

In his recent book, "Catching a Star: My Story of Hope", Suh talks about his childhood, his desire to help others, and life-changing encounters with patients.

He writes about a mother who gave birth to a child with multiple genetic and health challenges including a lack of clear vision because of cataracts. Doctors said the baby had just months to live. Suh said the mother begged him to do eye surgery on the child so that when her baby met her in heaven one day, the child would recognize her face.

Suh said he was deeply moved by the mother's request and told her, "I will give you my 100-percent so that the baby can see you after surgery."

He said, the next day, the baby couldn't stop staring at the mother's face. The child is now 3 and a half years old. "It's truly incredible," said Suh.

He believes vision played a large part in helping the child to live.

All proceeds from the sale of Suh's book will go toward medical missions and helping children to see.

His book is available on Amazon.

Originally posted here:
Omaha eye surgeon travels the world to offer vision and hope - KETV Omaha

Read More...

Connective Tissue Growth Factor Market Size, Share, Top Region, Key Players, Application,Status and Forecast 2027 – Redhill Local Councillors

Tuesday, February 18th, 2020

The market report envelopes an all-in information of the global Connective Tissue Growth Factor market and the nature of the market growth over the foreseeable period. The report provides a comprehensive elaboration of the positives and negatives of the global Connective Tissue Growth Factor market with DROT and Porters Five Forces analysis. With SWOT analysis, the report offers detailed insights about different players operating within the Connective Tissue Growth Factor market. In addition, the analysts of the report have served the qualitative and quantitative scrutinizing of different micro- and macro-economic factors influencing the global Connective Tissue Growth Factor market.

The Connective Tissue Growth Factor market report examines the consumption patter of each segment and the factors affecting the pattern. In addition, the report focuses on the production footprint of each segment in various industries and regions across the globe.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2550879&source=atm

The Connective Tissue Growth Factor market report helps the readers grasp the changing trend in the industry supply chain, manufacturing techniques and expenses, and current scenario of the end uses in the global Connective Tissue Growth Factor market.

All the players running in the global Connective Tissue Growth Factor market are elaborated thoroughly in the Connective Tissue Growth Factor market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the Connective Tissue Growth Factor market players.

The following manufacturers are covered:BLR Bio LLCFibroGen IncProMetic Life Sciences IncRXi Pharmaceuticals Corp

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeBLR-200IB-DMDOLX-201PBI-4050Others

Segment by ApplicationHypertrophic ScarsOpthalmologyGenetic DisordersLiver FibrosisOthers

Reports at discounted rates exclusively for new entrants!!! Offer end by midnight!!!

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2550879&source=atm

The Connective Tissue Growth Factor market report answers the following queries:

What the report encloses for the readers:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2550879&licType=S&source=atm

Why choose Connective Tissue Growth Factor Market Report?

See the article here:
Connective Tissue Growth Factor Market Size, Share, Top Region, Key Players, Application,Status and Forecast 2027 - Redhill Local Councillors

Read More...

Santen forges ophthalmology partnerships with Verily and WHO – Med-Tech Innovation

Tuesday, February 18th, 2020

Santen has forged two separate partnerships with Googles life sciences sister company Verilyand the International Telecommunication Union (ITU) whose initiative is supported by the World Health Organisation (WHO).

Both partnerships are aimed to drive the expansion of the latest technological innovations and digital solutions in ophthalmology across Europe and globally.

Combining Santens technology in the ophthalmology field and Verilys expertise in Artificial Intelligence (AI) and building hardware and software-based devices, the new company plans to develop and commercialise ophthalmic devices, including IoT medical devices.

Shigeo Taniuchi, president and COO of Santen said: Santen has actively promoted collaboration and open innovation with various external organisations in order to enhance the Quality of Life for people around the world through eye health. Digital technology is a transformational driver in health and we hope that this joint venture will be a significant step forward in transforming the way of eye care for people around the world.

Dimitri Azar, clinical lead, Opthalmology Programmes at Verily added: We are thrilled to partner with Santen, a global company with an established presence in the ophthalmology industry, to develop novel solutions leveraging AI and microelectronics for better eye care. By combining Santens eye care expertise and Verilys advanced technology, our joint venture is well-positioned to tackle innovative projects in ophthalmology diseases such as glaucoma, dry eye and other opthalmological diseases. Well explore ways to use technology not only to diagnose disease, but to improve disease management, and ultimately, further precision medicine in ophthalmology.

ITU will support Be He@lthy, Be Mobile (BHBM) and will focus preventable non-communicable diseases in the ophthalmology area with the aim of achieving eye health. BHBM is a digital health initiative between the WHO and the ITU in support of the WHO's expansion of services in non-communicable diseases.

This initiative is designed to raise awareness of the prevention and management of non-communicable diseases through the use of mobile phones and digital devices in order to realise healthy lifestyles. It is estimated that almost the entire world population (97%) lives within reach of a mobile cellular signal, and today its service is expanding digital health services and geographic reach, including the distribution of health information and content to end users through SMS (short message service) and digital device apps.

Doreen Bogdan-Martin, director of the ITU Telecommunication Development Bureau, said: "The participation of Santen in BHBM initiative highlights the importance of investing in technologies which can empower people to manage their own health and for medical professionals to better provide care from prevention to diagnosis and treatment. At ITU, we are expanding our partnership and collaboration with various stakeholders in order to bring the benefits of technology to the people, in every area and every walk of life."

The rest is here:
Santen forges ophthalmology partnerships with Verily and WHO - Med-Tech Innovation

Read More...

Lutein mkt projected to be valued at $454.8 mn by ’26, growing at 6.4% | FNB News – fnbnews.com

Thursday, February 13th, 2020

The global lutein market was calculated to be worth $274.6 million in the year 2018, and is projected to be valued at $454.8 million by the year 2026, delivering a CAGR of 6.4 per cent in that duration.

The rising incidences of cataract and age-related macular degeneration (AMD) have influenced the demand for lutein.

The fact that lutein is beneficial for the eyes and can protect and maintain healthy cells in the eyes, especially with our ever-increasing exposure to blue light, has led to the increased adoption of lutein supplements, and will subsequently bring to light more growth opportunities.

Lutein, an antioxidant carotenoid, is one of the two essential carotenoids that act as colour pigments in the human eye, and also gives the yellow colour to fruits and vegetables. In the eye, it acts as a light filter and prevents the eye tissues against damages caused by sunlight.

This article has been designed to encompass all vital aspects of the lutein industry that influence the growth of the sector. The companies functioning in the sector are undertaking strategic initiatives to gain a competitive advantage against all rival companies.

The major companies operating in the industry are Allied Biotech, BASF, Chr. Hansen, Dhler, DDW The Color House, E I D Parry, Fenchem, Lycored, PIVEG, and Zhejiang Medicine.

Back in 2015, DSM and Kemin had extended their partnership, launching FloraGlo Lutein, an eye health solution suitable for effective eye health ingredients.

In September 2019, the US-based company EyePromise debuted Screen Shield Pro as the latest addition to its eye vitamin range.

The product has been created with lutein and naturally-derived zeaxanthin to help prevent the eyes from damage caused by screens.

Based on form, lutein is mainly available in the forms of powder and crystalline, oil suspension, beadlet, and emulsion, whereas based on source, lutein is derived from natural as well as synthetic sources, and have major applications in the food and beverages sector.

Based on source, natural lutein is estimated to achieve a sizable growth due to the health benefits it offers.

However, synthetic lutein will dominate the market as it is easy to manufacture and are cost comparatively less than natural lutein.

The integration of lutein into dietary supplements will account for 27.4 per cent of the global market share.

Lutein has found extensive usage in eye care supplements and can also effectively prevent breast cancer, colon cancer, type 2 diabetes, and heart diseases.

The market extends to five major regions across the globe, viz., North America, Europe, Asia Pacific, Latin America, and the Middle-East and Africa.

Reports and Data estimates that the lutein market in the North American region will control the biggest portion of the global industry, and the Asia Pacific market will register the highest growth rate of 8.2 per cent in the forecast duration between 2020 and 2026.

The rising incidences of cataract and AMD in the region will drive the demand for the product in the region.

Data from the American Academy of Opthalmology indicates that nearly 24.4 million Americans aged 40 and older are affected by cataract, while almost 2.1 million Americans over 50 have late AMD, which leads to severe vision impairment.

Overall, the global lutein market exhibits tremendous growth potential for this decade, primarily originating from the increasing awareness among the population regarding the numerous health benefits of consuming lutein.

Read more:
Lutein mkt projected to be valued at $454.8 mn by '26, growing at 6.4% | FNB News - fnbnews.com

Read More...

Stem Cell Treatments Market to Exhibit Impressive Growth of CAGR during the per – News by aeresearch

Thursday, February 13th, 2020

Latest Research Report on Stem Cell Treatments Market size | Industry Segment by Applications (Nerve Diseases, Immunological Diseases, Musculoskeletal Disorders, Cardiovascular Diseases, Gastrointestinal Diseases and Other), by Type (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone Marrow-Derived Mesenchymal Stem Cells, Cord Blood/Embryonic Stem Cells and Other Cell Sources), Regional Outlook, Market Demand, Latest Trends, Stem Cell Treatments Industry Growth, Share & Revenue by Manufacturers, Company Profiles, Forecasts 2025.Analyzes current market size and upcoming 5 years growth of this industry.

New research report to its expanding repository. The research report, titled Stem Cell Treatments Market, mainly includes a detailed segmentation of this sector, which is expected to generate massive returns by the end of the forecast period, thus showing an appreciable rate of growth over the coming years on an annual basis. The research study also looks specifically at the need for Stem Cell Treatments Market.

Our Report Offerings Include:

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/72554

Report Scope:

The study includes the profiles of key players in the Stem Cell Treatments market with a significant global and/or regional presence. The Stem Cell Treatments market competition by Top Manufacturers Covers:

By Product:

By Application:

Points Covered in The Report:

Recent Industry Trend:

The report contains the profiles of various prominent players in the Global Stem Cell Treatments Market. Different strategies implemented by these vendors have been analyzed and studied to gain a competitive edge, create unique product portfolios and increase their market share. The study also sheds light on major global industry vendors. Such essential vendors consist of both new and well-known players. Besides, the business report contains important data relating to the launch of new products on the market, specific licenses, domestic scenarios and the strategies of the organization implemented on the market.

MAJOR TOC OF THE REPORT:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/72554

View post:
Stem Cell Treatments Market to Exhibit Impressive Growth of CAGR during the per - News by aeresearch

Read More...

Ophthalmology | Definition of Ophthalmology by Merriam-Webster

Monday, February 10th, 2020

To save this word, you'll need to log in.

: a branch of medical science dealing with the structure, functions, and diseases of the eye

These example sentences are selected automatically from various online news sources to reflect current usage of the word 'ophthalmology.' Views expressed in the examples do not represent the opinion of Merriam-Webster or its editors. Send us feedback.

circa 1842, in the meaning defined above

borrowed from German Ophthalmologie, from ophthalmo- ophthalmo- + -logie -logy

Cite this Entry

Ophthalmology. Merriam-Webster.com Dictionary, Merriam-Webster, https://www.merriam-webster.com/dictionary/ophthalmology. Accessed 10 Feb. 2020.

More Definitions for ophthalmology

: a branch of medical science dealing with the structure, functions, and diseases of the eye

Other Words from ophthalmology

Comments on ophthalmology

What made you want to look up ophthalmology? Please tell us where you read or heard it (including the quote, if possible).

Read the original here:
Ophthalmology | Definition of Ophthalmology by Merriam-Webster

Read More...

New Jersey Ophthalmology – City Directory

Monday, February 10th, 2020

Learn more about Ophthalmology Specialists

Anoptometristis a healthcare provider who specializes in routine and preventive eye and vision care. Optometrists diagnose vision abnormalities and prescribe eyeglasses and contacts. They detect and treat cataracts, glaucoma, and eye infections. Optometrists also screen for conditions that affect the eyes and vision, includinghigh blood pressureand diabetes.

An optometrist typically:

Evaluates a patients medical and vision history

Educates the patient about eye and vision disease prevention and health

Performs a comprehensive eye and vision exam and evaluates blood pressure

Performs and interprets specialized eye tests

Diagnoses and often treats acute and chronic eye diseases and conditions that affect vision, including eye injuries, vision problems, cataracts, and glaucoma

Screens for conditions that increase the risk of eye and vision conditions including diabetes and high blood pressure

Prescribes eye glasses, contacts, and certain medications

Refers patients to an ophthalmologist for serious eye problems and most eye surgeries

Performs laser or glaucoma surgeries in some cases

Provides eye and vision care before and after eye surgery

An optometrist may also be known by the following names:eye doctor, vision care specialist, and Doctor of Optometry (OD).

There are 743 specialists practicing Ophthalmology in New Jersey with an overall average rating of 4.1 stars. There are 111 hospitals in New Jersey with affiliated Ophthalmology specialists, including Valley Hospital, Saint Barnabas Medical Center and Clara Maass Medical Center.

Original post:
New Jersey Ophthalmology - City Directory

Read More...

Opthalmology Pacs Market 2020 Size by Top Global Leading Players, Opportunities, Revenue Growth, Trends, Outlook and Forecasts to 2025 – TechNews.mobi

Monday, February 10th, 2020

In the past, there was a substantial growth in the elderly population and the occurrence of the disorders related to age, involves eye disorders. Opthalmology PACS is the main factor fueling the demand for the inventive technologies for the treatment and diagnosis of the ophthalmic conditions driving the ophthalmology PACS market. Layer of tear is losing the stability and damages rapidly in the geriatric population, as a result, risk of having the severe eye disorders are increasing substantially with age after 60 years. These eye disorders are involving the conditions like cataract, diabetic eye disease, glaucoma, low vision and macular degeneration.

Request a sample of this report @https://www.adroitmarketresearch.com/contacts/request-sample/608

Most of the people with the eye diseases are increasing worldwide, and the loss of vision is the main concern amongst the individuals. Increase in the occurrence of the chronic diseases like hypertension, diabetes and aging population are increasing the occurrence of the eye disorders like ocular hypertension and diabetic retinopathy are boosting the global ophthalmology PACS market. Maximum blind population or those suffering from less vision is anticipated to grow significantly and increase the ophthalmology PACS market share. Opthalmology PACS are efficiently used in the production of the image data eradicating the physical restraints related to the communication of the radiologic image on film.

Increase in the occurrence of the eye disorders is creating it habitual for the ophthalmologists to instruct the unique methods of treatment. Various regions are having the high rate of accepting the ophthalmology PACS because of the increase in awareness amongst the healthcare professionals and the general population. Factors that are responsible for the growth of ophthalmology PACS market are shortage of ophthalmologists, increase in the acceptance of teleophthalmology, increase in the eye diseases and growth in the elderly population. Although, implementing the PACS is of high price, more training required, fault in the system results in the loss of images are the drawbacks that are hampering the global ophthalmology PACS market growth. PACS is the picture archiving and communications system (PACS) referring a computer system that are displaying, capturing and storing medical images. Integrated PACS are having various advantages like cost-effectiveness, data security, reliability, use and easy establishment. PACS are analyzing and manipulating the image, provides effective data management and transport and saves the cost of printing, lessen the waiting time for patients. These advantages are playing the major role for accepting the PACS and are fueling the growth of ophthalmology PACS market.

Browse the complete report @https://www.adroitmarketresearch.com/industry-reports/opthalmology-pacs-market

Global ophthalmology PACS market is segmented into end-use, type, delivery model and region. On the basis of end-use, market is divided into hospitals, Ambulatory Surgical Center (ASCS) & Specialty Clinics and more. Based on type, market is divided into standalone PACS and integrated PACS. On considering the delivery model, market is divided into cloud/ web based models, on-premise models and more.

Geographically, regions involved in the development of global ophthalmology PACS market share are Europe, North America, Asia Pacific and Latin America. North America is anticipated to hold the largest ophthalmology market share in the coming future. Asia Pacific is estimated to grow at the highest CAGR over the forecast period.

Key players involved in increasing the global ophthalmology PACS market size are Topcon Corporation, IBM corporation, Carl Zeiss Meditec AG, EyePACS, Heidelberg Engineering and more.

Key Segments in the Global Ophthalmology PACS Market are-

By End-Use, market is segmented into:

Hospitals

Ambulatory Surgical Center (ASCS) & Specialty Clinics

Others

By Type, market is segmented into:

Standalone PACS

Integrated PACS

By Delivery Model, market is segmented into:

Cloud/ web based models

On-premise models

Others

By Regions market is segmented into:

Europe

North America

Asia-Pacific

Latin America

What to expect from the Global Ophthalmology PACS Market report?

Predictions of future made for this market during the forecast period.

Information on the current technologies, trends, devices, procedures, and products in the industry.

Detailed analysis of the market segmentation, depending on the types, devices, and products.

Government regulations and economic factors affecting the growth of the market.

An insight into the leading manufacturers.

Regional demographics of the market.

Who should buy this report?

Venture capitalists, Investors, financial institutions, Analysts, Government organizations, regulatory authorities, policymakers ,researchers, strategy managers, and academic institutions looking for insights into the market to determine future strategies

Enquire for in-depth information before buying this report @https://www.adroitmarketresearch.com/contacts/enquiry-before-buying/608

About Us:

Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a markets size, key trends, participants and future outlook of an industry. We intend to become our clients knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Info:

Ryan Johnson

Adroit Market Research

3131 McKinney Ave Ste 600,

Dallas, Texas 75204, U.S.A

Phone No: + +19723628199

Email:[emailprotected]

The rest is here:
Opthalmology Pacs Market 2020 Size by Top Global Leading Players, Opportunities, Revenue Growth, Trends, Outlook and Forecasts to 2025 - TechNews.mobi

Read More...

Celebrating 47th anniversary of CEITC – The Daily Star

Monday, February 10th, 2020

Chittagong Eye Infirmary and Training Complex (CEITC) celebrated its 47th anniversary at its complex at the port citys Foys Lake on Saturday.

The celebration of the complex rendering service in eye care, which has been in place since 1973, began through the seminar on "Community Opthalmology" on Saturday morning.

Nine renowned personalities, who contributed to education and health, were honoured with gold medals.

National professor Dr Jamilur Reza Chowdhury handed out the medals to the awardees.

They included: Dr Frank Billson, a professor at the University of Sydney who fought against avoidable blindness in Asia-Pacific region; Dr Thulasiraj Ravilla, a renowned ophthalmologist of India and Bob Ranck, chief executive of Orbis International.

Besides, internationally-acclaimed childrens rights hero Rosi Gollmann, Dr R Pararajasegaram, famous opthalmologist of Sri Lanka; Dr Zafrullah Chowdhury, founder of Gonoshastha Kendra, and national professor Dr Abdul Malek, a prominent cardiologist of Bangladesh, were honoured at the ceremony.

Apart from the aforementioned, two posthumous honours were also conferred the late Zahur Ahmed Chowdhury, a former minister of health, labour and social welfare and the late professor MA Matin, also a former minister.

Dr Jamilur Reza Chowdhury, chief guest at the programme, said, "The small step taken in 1972 has now become a great shelter for people in need of eyecare. Thousands of students were trained in specialised eyecare from CEITC. They are playing a great role in fighting visual impairment," he added.

He urged CEITC to work to increase the number of eye donors as it was very small in proportion to the country's population.

Mahfuz Anam, editor of The Daily Star, also took part in the anniversary and visited the newly-built Imperial Hospital with Dr Robiul Hossain, managing trustee of CEITC.

MA Malek, editor and publisher of local Daily Azadi, chaired the second session of the anniversary.

Professor Shireen Akther, vice-chancellor of Chattogram University, Mahtab Uddin Chowdhury, president of Awami League, city unit and Sufi Mohammad Mizanur Rahman, chairman of PHP family were present among others.

See the rest here:
Celebrating 47th anniversary of CEITC - The Daily Star

Read More...

Global Camera Modules Market Worth $44.6 Billion by 2025 – Increasing Trends of Multiple Camera-Based Smartphones, Growing Applications of AR and VR…

Monday, February 10th, 2020

Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Camera Modules Market by Component (Image Sensors, Lens Modules, Voice Coil Motors), Focus Type (Fixed, Auto), Interface, Pixel, Process, Application (Consumer Electronics, Automotive, Security & Surveillance), and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global camera modules market size is projected to grow from USD 31.5 billion in 2020 to USD 44.6 billion by 2025, recording a CAGR of 7.2%.

Increasing trends of multiple camera-based smartphones to drive camera modules market.

Rising public safety and security concerns led to the adoption of surveillance cameras, technological advancements in components of camera modules for its integration in devices, and rising demand for ToF cameras in smartphones are driving the growth of the camera modules industry. However, constraints such as high cost of multi-camera systems deployment in vehicles may hinder the market growth.

Consumer electronics to be largest market for camera modules throughout forecast period.

Consumer electronics is one of the highly competitive industries which observes rapid technological advancements due to continuous change in consumer demands. Smartphones derive significantly higher market for camera modules in consumer electronics applications due to the increasing trend of multiple camera smartphones. To improve functionality and quality of images produced by smartphones and rising trends of front cameras, OEMs are shifting from single rear cameras to dual, triple, and quad-camera designs, resulting in increasing adoption of an average number of camera modules per smartphone.

For instance, in September 2019, Apple launched a new range of iPhones, including iPhone 11, iPhone 11 Pro, and iPhone 11 Pro Max. iPhone 11 features dual camera, each having 12 MP resolution while iPhone 11 Pro and iPhone Pro Max feature triple cameras, each with 12 MP resolution. Other leading smartphone OEMs such as Samsung, Xiaomi, and Huawei are introducing smartphones featuring multiple cameras. Xiaomi is already set to introduce Mi Note 10 in early 2020 with a 108 MP rear camera among 4 other rear cameras. These developments are expected to play an important role in the growth of the camera modules market during the forecast period.

APAC to record highest growth rate during forecast period.

APAC is likely to be the fastest-growing region for the camera modules market in the coming years. The factors contributing to the significant growth rate of APAC in camera modules market, along with the largest market share, include the presence of leading smartphone manufacturers such as Samsung, Huawei, Oppo, and Xiaomi. Smartphones assist consumer electronics applications to constitute a significant share in the camera modules market.

China is a base for several camera modules as well as consumer electronics products manufacturers. Different camera-related smartphone trends in the country are expected to draw new opportunities for the camera modules market. Several factors, such as government mandates based on the autonomy of vehicles in China, will assist camera modules market to propel. Automotive players in Japan are introducing new safety functions using camera modules, which is expected to induce high market growth.

Key Topics Covered

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights 4.1 Attractive Opportunities in Camera Modules Market4.2 Market in APAC, By Component and Application4.3 Camera Module Market, By Interface4.4 Country-Wise Camera Modules Market Growth Rate

5 Market Overview 5.1 Introduction5.2 Value Chain Analysis5.3 Market Dynamics5.3.1 Drivers5.3.1.1 Increasing Trends of Multiple Camera-Based Smartphones5.3.1.2 Rising Public Safety and Security Concerns Lead to Adoption of Surveillance Cameras5.3.1.3 Technological Advancements in Components of Camera Modules for Integration in Devices5.3.1.4 Rising Demand for Tof Camera in Smartphones5.3.2 Restraints5.3.2.1 High Cost of Multi-Camera Systems Deployment in Vehicles5.3.3 Opportunities5.3.3.1 Government Initiatives to Increase Vehicle Safety is Leading to Adoption of ADAS5.3.3.2 Emergence of Autonomous Vehicles5.3.3.3 Growing Applications of AR and VR Devices5.3.4 Challenges5.3.4.1 Managing Image From Multiple Cameras in Smartphone May Limit Processing Power

6 Camera Modules Market, By Component 6.1 Introduction6.2 Image Sensors6.2.1 CMOS Image Sensors6.2.1.1 Frontside Illumination (FSI) Technology6.2.1.1.1 Manufacturing Process of FSI is Simple and Low-Cost6.2.1.2 Backside Illumination (BSI) Technology6.2.1.2.1 Increasing Adoption of Higher Megapixel Cameras in Various Applications to Drive the Growth of Market6.2.2 CCD Image Sensors6.2.2.1 CCD Image Sensors are Used in Professional, Medical, and Scientific Applications6.2.3 Other Image Sensors6.2.3.1 NMOS Image Sensors6.2.3.2 InGaAs Image Sensors6.2.3.3 sCMOS Image Sensors6.3 Lens Modules6.3.1 Consumer Applications Hold Major Share of Camera Lens Modules Market6.4 Voice Coil Motors6.4.1 APAC to Provide Opportunities for VCM Market Owing to Presence of Large Number of OEMs6.5 Other Components

7 Camera Modules Market, By Focus Type 7.1 Introduction7.2 Fixed Focus7.2.1 Growth is Driven By Increasing Adoption of Cameras in Automotive and Surveillance Applications7.3 Autofocus7.3.1 Emerging Applications Such as Robotics, Drones, ARtificial Intelligence, and Wearables Would Provide Growth Opportunities

8 Camera Modules Market, By Interface 8.1 Introduction8.2 Camera Serial Interface8.2.1 Better Performance of CSI to Provide Growth Opportunity Formarket8.3 Camera Parallel Interface8.3.1 APAC to Create Opportunities for Camera Modules With Parallel Interface

9 Camera Modules Market, By Pixels 9.1 Introduction9.2 Up to 7 MP9.2.1 ADAS and Smartphones Provide Opportunity for Market9.3 8 to 13 MP9.3.1 Rising Trends of Multiple and High Megapixel Camera-Based Smartphones to Driver Market Growth9.4 Above 13 MP9.4.1 Technological Advancements in Smartphones and Demand for Better Image Quality Would Propel Market Growth

10 Camera Modules, By Process 10.1 Introduction10.2 Flip-Chip Camera Module10.3 Chip-On-Board Camera Module

11 Camera Modules Market, By Application 11.1 Introduction11.2 Consumer Electronics11.2.1 Smartphones11.2.1.1 OEM's Shift From Single Rear Cameras to Dual, Triple, and Quad Camera Designs in Smartphones Drives Market11.2.2 Tablet PC11.2.2.1 Rising Adoption of Tablet PCS to Create Opportunity for Market11.2.3 Camera11.2.3.1 Rising Interests of Consumers for Photography to Drive Growth of Market11.2.4 Wearable11.2.4.1 Emerging Technologies Such as AR and VR to Provide Opportunity for Market11.2.5 Others11.3 Automotive11.3.1 By Function11.3.1.1 ADAS11.3.1.1.1 Stringent Government Regulations to Boost Adoption of Automotive Cameras11.3.1.2 Viewing11.3.1.2.1 Rising Trends of OEMs to Provide Advanced Technologies in Vehicle to Drive Growth of Market11.3.2 By View Type11.3.2.1 Rear View11.3.2.1.1 APAC to Grow at Highest CAGR for Camera Modules Market for Rear View Application11.3.2.2 Front View & Others11.3.2.2.1 Camera Modules Market to Grow at Higher Rate for Front View & Other Applications11.3.3 By Vehicle Type11.3.3.1 Passenger Car11.3.3.1.1 Passenger Car Segment to Dominate Camera Modules Market11.3.3.2 Commercial Vehicles11.3.3.2.1 North America to Lead Camera Modules Market for Commercial Vehicles During Forecast Period11.4 Healthcare11.4.1 Endoscopy11.4.1.1 Technological Advancements in Healthcare Industry to Drive Market Growth11.4.2 Opthalmology11.4.2.1 Increasing Adoption of Imaging Technology in Medical Applications to Provide Opportunity for Market11.4.3 Others11.5 Industrial11.5.1 Machine Vision11.5.1.1 Rising Industrial Automation and Adoption of Industrial IoT Solutions Trends Provide Growth Opportunities11.5.2 Robotic Vision11.5.2.1 Increasing Adoption of Advanced Technologies in Industrial Manufacturing to Create Growth Opportunity for Market11.6 Security & Surveillance11.6.1 Public Places & Infrastructures11.6.1.1 Increasing Government Projects of Smart Cities to Provide Opportunity for Market11.6.2 Commercial & Residential11.6.2.1 Increasing Safety and Security Concerns to Drive Market Growth11.7 Aerospace & Defense11.7.1 Airborne and Marine Surveillance11.7.1.1 Rising Adoption of Cameras for Aerial Vehicles to Provide Opportunity for Market11.7.2 Border Surveillance & Military Operations11.7.2.1 Increased Border Surveillance By Governments to Drive Market

12 Geographic Analysis 12.1 Introduction12.2 North America12.3 Europe12.4 APAC12.5 Rest of the World

13 Competitive Landscape 13.1 Overview13.2 Market Ranking Analysis13.2.1 Product Launches and Developments13.2.2 Agreements, Partnerships, and Collaborations13.2.3 Expansions13.2.4 Acquisitions13.3 Competitive Leadership Mapping13.3.1 Visionary Leaders13.3.2 Innovators13.3.3 Dynamic Differentiators13.3.4 Emerging Players

14 Company Profiles 14.1 Introduction14.2 Key Players14.2.1 LG Innotek14.2.2 Sunny Optical Technology (Group)14.2.3 Sharp14.2.4 Samsung Electro-Mechanics14.2.5 OFILM Tech14.2.6 AMS14.2.7 Chicony14.2.8 MCNEX14.2.9 Primax Electronics14.2.10 Q Technology14.3 Right to Win14.4 Other Key Players14.4.1 CAMMSYS14.4.2 Cowell14.4.3 E-Con Systems14.4.4 Haesung Optics14.4.5 Jenoptik14.4.6 Kyocera14.4.7 Leopard Imaging14.4.8 Luxvisions Innovation Limited14.4.9 Partron14.4.10 Shenzhen CM Technology Company Ltd.14.4.11 Truly Opto-Electronics

Story continues

For more information about this report visit https://www.researchandmarkets.com/r/n7ill5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Read more:
Global Camera Modules Market Worth $44.6 Billion by 2025 - Increasing Trends of Multiple Camera-Based Smartphones, Growing Applications of AR and VR...

Read More...

Cryochambers Market Analysis, Size, Regional Outlook, Competitive Strategies and Forecasts to 2026 – Technology Magazine

Sunday, January 26th, 2020

The Cryochambers market study added by Market Study Report, LLC, exhibits a comprehensive analysis of the growth trends present in the global business scenario. The study further presents conclusive data referring to the commercialization aspects, industry size and profit estimation of the market. The study also illustrates the competitive standing of leading manufacturers in the projection timeline whilst incorporating their diverse portfolio and regional expansion endeavors.

The Cryochambers market report presents a detailed assessment of the industry vertical and it also elaborates about the dual perspective- production and consumption.

Considering the production aspect, the study provides details regarding the manufacturing of the product, product renumeration, and the gross margins of the firms manufacturing the product. Speaking of the consumption, the report includes data related to the product consumption value and the product consumption volume along with the import and export status of the products.

Request a sample Report of Cryochambers Market at:https://www.marketstudyreport.com/request-a-sample/2450123?utm_source=technologymagazine&utm_medium=Kunal

An overview of the regional landscape:

Regional segmentation: North America, Europe, Asia Pacific, Middle East & Africa, Latin America.

Details mentioned in this section

The report offers an in-depth assessment of the regional territory of this industry.

Data provided in the study:

An overview of the product spectrum:

Product segmentation:

Details mentioned in this section

The report evaluates data with regards to the product reach.

Data provided in the study:

An idea of the application terrain:

Application segmentation:

Details mentioned in this section

Reports can be segmented with respect to the application spectrum.

Ask for Discount on Cryochambers Market Report at:https://www.marketstudyreport.com/check-for-discount/2450123?utm_source=technologymagazine&utm_medium=Kunal

Data provided in the study:

An idea of the competitive reach:

Competitive segmentation:

Details mentioned in this section

Report provides details related to the competitive spectrum of the Cryochambers market.

Data provided in this section:

The report provides data relating growth margins of these firms along with the product costs, renumeration, and manufacturing expenses.

It also provides data that reveals the extent to which the industry has been evaluated. Also, the report contains data about the analysis of the feasibility of the new investment projects that have commenced along with the research conclusions inferred from the studies.

For More Details On this Report:https://www.marketstudyreport.com/reports/global-cryochambers-market-research-report-2020-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

Some of the Major Highlights of TOC covers:

Development Trend of Analysis of Cryochambers Market

Marketing Channel

Market Dynamics

Methodology/Research Approach

Related Reports:

1. Global Opthalmology Drugs and Devices Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026Opthalmology Drugs and Devices market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.Read More: https://www.marketstudyreport.com/reports/global-opthalmology-drugs-and-devices-market-research-report-2020-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

2. Global Metastatic Cancer Treatment Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026Metastatic Cancer Treatment Market report characterize imperative Portion and contenders of the market regarding market estimate, volume, esteem. This report likewise covers every one of the locales and nations of the world, which demonstrates a territorial improvement status, it additionally incorporates Business Profile, Introduction, Revenue and so on.Read More: https://www.marketstudyreport.com/reports/global-metastatic-cancer-treatment-market-research-report-2020-segment-by-key-companies-countries-types-applications-and-forecast-2021-to-2026

Read More Reports On: https://www.marketwatch.com/press-release/furniture-market-trends-2019-industry-analysis-top-manufacturers-application-opportunities-forecast-to-2024-2020-01-08

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

The rest is here:
Cryochambers Market Analysis, Size, Regional Outlook, Competitive Strategies and Forecasts to 2026 - Technology Magazine

Read More...

Connective Tissue Growth Factor Market outlook & growth prediction by players (Genetic Disorders , Liver Fibrosis , Others, BLR Bio LLC ) -…

Monday, January 13th, 2020

A qualitative research study accomplished by HTF MI titled Global Connective Tissue Growth Factor Market covers detailed Product / Industry Scope, current and future market size scenario and elaborates outlook and status to 2025 provides primary data, studies and vendor briefings. The market Study is segmented by key regions along with country level break-up which is accelerating the marketization and by products type, application/end-users. The research study provides estimates for Connective Tissue Growth Factor forecast till 2025. Some of the Major Players Included in the study are BLR-200, IB-DMD, OLX-201, PBI-4050, Others, Demand Coverage (Market Size & Forecast, Consumer Distribution):, Hypertrophic Scars, Opthalmology, Genetic Disorders, Liver Fibrosis, Others, BLR Bio LLC, FibroGen Inc, ProMetic Life Sciences Inc, RXi Pharmaceuticals Corp, North America, Europe, Asia-Pacific, South America & Middle East & Africa.

Get Free Sample Report + All Related Graphs & Charts @:https://www.htfmarketreport.com/sample-report/2214003-global-connective-tissue-growth-factor-market-study-2016-2026-by-segment

1) Can we add or profile new players as per our need?

Yes, we can add or profile new company as per client need in the report. Final confirmation to be provided by research team depending upon the difficulty of survey.

** Data availability will be confirmed by research in case of privately held company. Up to 3 players can be added at no added cost.

2) Can inclusion of additional Segmentation / Market breakdown is possible?Yes, inclusion of additional segmentation / Market breakdown is possible subject to data availability and difficulty of survey. However a detailed requirement needs to be shared with our research before giving final confirmation to client.

** Depending upon the requirement the deliverable time and quote will vary.

3) HowResearch Report is an Interesting One?

This report covers the current scenario and growth prospects of Global Connective Tissue Growth Factor for the period 2019 2025. The study is a professional and in-depth study with around n- no. of tables and figures which provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the domain.

The titled segments and sub-section of the market are illuminated below:

The Global Connective Tissue Growth Factor market has been divided into, application, type and region.

On The Basis Of Type, Market is segmented by , by Application it includes

Some of the Key Players Identified are BLR-200, IB-DMD, OLX-201, PBI-4050, Others, Demand Coverage (Market Size & Forecast, Consumer Distribution):, Hypertrophic Scars, Opthalmology, Genetic Disorders, Liver Fibrosis, Others, BLR Bio LLC, FibroGen Inc, ProMetic Life Sciences Inc, RXi Pharmaceuticals Corp, North America, Europe, Asia-Pacific, South America & Middle East & Africa

Geographic Segmentation includes North America, Europe, Asia-Pacific etc

***Sub Regions Included: North America [United States, Canada, Mexico], Asia-Pacific [China, India, Japan, South Korea, Australia, Indonesia, Malaysia, Philippines, Thailand, Vietnam], Europe [Germany, France, UK, Italy, Russia, Rest of Europe], South America [Brazil, Argentina, Rest of South America], Middle East & Africa [GCC Countries, Turkey, Egypt, South Africa, Rest of Middle East & Africa]

*** Unless until specified in Original TOC

To know more about the table of contents, you can click @https://www.htfmarketreport.com/reports/2214003-global-connective-tissue-growth-factor-market-study-2016-2026-by-segment

Furthermore, the years considered for the study are as follows:Historical year 2013-2018Base year 2018Forecast period** 2019 to 2025 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Major Key Features Covered in Global Connective Tissue Growth Factor Market Report:

* To gain insightful analyses of the market and have comprehensive understanding of the Global Connective Tissue Growth Factor and its commercial landscape.* Assess the Connective Tissue Growth Factor production processes, major issues, and solutions to mitigate the development risk.* To understand the most affecting driving and restraining forces in the Connective Tissue Growth Factor and its impact in the global market.* Learn about the market strategies that are being adopted by leading respective organizations.* To understand the future outlook and prospects for Connective Tissue Growth Factor Market.

Buy this research report @https://www.htfmarketreport.com/buy-now?format=1&report=2214003

Queries we have tried to answered in Global Connective Tissue Growth Factor Market Study:Who are the Leading key players and what are their Key Business strategies in the Global Connective Tissue Growth Factor?What are the key consequences of the five forces analysis of the Connective Tissue Growth Factor?What are different opportunities and threats faced by the dealers in the Global Connective Tissue Growth Factor?What are the strengths and weaknesses and business strategies of the key vendors?

Some Extracts from Table of Contents:Chapter 1. Market OverviewChapter 3. Market DynamicsChapter 4. Research MethodologyChapter 5. Market Factor AnalysisChapter 6. Global Connective Tissue Growth Factor Market, By Delivery ModeChapter 7. Global Connective Tissue Growth Factor Market, By ApplicationChapter 8. Global Connective Tissue Growth Factor Market, By RegionChapter 9. Global Connective Tissue Growth Factor Market, By TypeChapter 10. Company LandscapeChapter 11. Company ProfilesChapter 12. Appendix

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Author:HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the Accurate Forecast in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their Goals & Objectives.

Contact US :Craig Francis (PR & Marketing Manager)HTF Market Intelligence Consulting Private LimitedUnit No. 429, Parsonage Road Edison, NJNew Jersey USA 08837Phone: +1 (206) 317 1218[emailprotected]

Connect with us atLinkedIn|Facebook|Twitter

Excerpt from:
Connective Tissue Growth Factor Market outlook & growth prediction by players (Genetic Disorders , Liver Fibrosis , Others, BLR Bio LLC ) -...

Read More...

Scientists reveal what life in space does to your eyes – Inverse

Monday, December 30th, 2019

When astronaut Michael Barratt returned to Earth in October 2009, he revealed that something strange had happened during his eight months in microgravity on board the International Space Station: His vision had changed.

Before his sojourn above the Earth, Barratt needed glasses to see at a distance. But once he returned from his mission in space, the astronaut also needed reading glasses to see up-close.

Barratts curious case, as well as reports of similar changes from several other astronauts, launched a series of studies on the effects of spaceflight on vision. If humans are to spend any significant time in space, scientists need to know how time spent in the microgravity environment may alter our eyes and if the changes are permanent.

The cause of the changes Barratt experienced are still unclear, but scientists hypothesize that increased pressure caused by fluid going into astronauts heads as a result of being suspended in a microgravity environment could be reshaping their optic nerve changing the structure of their eyes.

In a study published this week in the journal JAMA Opthalmology, scientists recreated the weightlessness experienced by astronauts in space on 11 people here on Earth in an effort to better understand what effect the environment has on vision. The findings may help develop countermeasures to mitigate the effects of spaceflight on astronauts eyes better preparing them for longer flights in space.

The participants were kept on bedrest for 30 days, with their heads tilted down a state supposed to simulate the physiological effects of weightlessness in space. Any changes to their optical nerves observed over the course of the study were compared with data collected from 20 astronauts who had spent around 30 days in space from the years 2012 to 2018.

Over the 30-day period, the participants developed significant swelling of their optic nerve at the back of the eye due to a buildup of fluid around the brain. Although the effects were not entirely parallel with those seen in the astronauts, the differences between the two data sets may still provide insight on the phenomenon.

Contrary to past theories, the results suggest that increased intracranial pressure, or increased pressure around the brain, as a result of fluid build-up may not be the only cause of vision changes among astronauts. In fact, the Earth-bound participants intracranial pressure levels decreased with increased weightlessness.

The results also run contrary to the theory that gender may play a role in changes to vision during spaceflight. In one of the initial studies conducted between 2012 and 2018, NASA noted that half of the astronauts onboard the International Space Station had experienced changes in vision, but none of the female astronauts had developed the same symptoms.

This study, by contrast, involved six men and five women, and the female participants also experienced swelling of their retinas.

The study also found that participants developed more severe symptoms on their right eye versus their left. This reflects the earlier results obtained from the astronauts data, suggesting that there may be asymmetry in how each eye is affected.

The results dont answer the question of how long these effects may last. In Barratts case, he reported that his right eye was permanently altered by his time in space, while his left eye returned to its pre-space condition suggesting some of the effects of weightlessness on the body may remain for years after astronauts come back down to Earth.

Read this article:
Scientists reveal what life in space does to your eyes - Inverse

Read More...

Absorbable and Non-Absorbable Sutures Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 – Market Reports Observer

Thursday, December 26th, 2019

Global Absorbable and Non-Absorbable Sutures Market Report 2019 Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Absorbable and Non-Absorbable Sutures industry.

The report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.

There are 4 key segments covered in this report: competitor segment, product type segment, end use/application segment and geography segment.

Make An EnquiryAbout This Report @ https://www.marketresearchhub.com/enquiry.php?type=E&repid=2574402&source=atm

For competitor segment, the report includes global key players of Absorbable and Non-Absorbable Sutures as well as some small players.

B. Braun Melsungen AGEthiconSmith & NephewDemetech CorporationConmed CorporationW.L. Gore & AssociatesTephaMeta BiomedZimmer BiometCP MedicalMiltex (A Integra LifeSciences Corporation Company)Assut Medical SarlDyNek PtyFootbergStoeltingUnimed Medical IndustriesTeleflex IncorporatedBoston Scientific CorporationMedtronicSurgical Specialties Corporation

Segment by RegionsNorth AmericaEuropeChinaJapanSoutheast AsiaIndia

Segment by TypeAbsorbable SuturesNon-Absorbable Sutures

Segment by ApplicationCardiovascularOrthopedicGynecologyOpthalmologyGeneral SurgeryOthers

Request Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2574402&source=atm

Important Key questions answered in Absorbable and Non-Absorbable Sutures market report:

What will the market growth rate, Overview, and Analysis by Type of Absorbable and Non-Absorbable Sutures in 2024?

What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Absorbable and Non-Absorbable Sutures market?

What is Dynamics, This Overview Includes Analysis of Scope and price analysis of top Manufacturers Profiles?

Who Are Opportunities, Risk and Driving Force of Absorbable and Non-Absorbable Sutures market? Knows Upstream Raw Materials Sourcing and Downstream Buyers.

Who are the key manufacturers in space? Business Overview by Type, Applications, Gross Margin, and Market Share

What are the opportunities and threats faced by manufacturers in the global market?

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2574402&licType=S&source=atm

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Absorbable and Non-Absorbable Sutures product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Absorbable and Non-Absorbable Sutures , with price, sales, revenue and global market share of Absorbable and Non-Absorbable Sutures in 2019 and 2015.

Chapter 3, the Absorbable and Non-Absorbable Sutures competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Absorbable and Non-Absorbable Sutures breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2019 to 2025.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2019 to 2025.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2019 to 2025.

Chapter 12, Absorbable and Non-Absorbable Sutures market forecast, by regions, type and application, with sales and revenue, from 2019 to 2025.

Chapter 13, 14 and 15, to describe Absorbable and Non-Absorbable Sutures sales channel, distributors, customers, research findings and conclusion, appendix and data source.

This post was originally published on Market Reports Observer

Read more:
Absorbable and Non-Absorbable Sutures Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 - Market Reports Observer

Read More...

Absorbable and Non-Absorbable Sutures Market Research, Recent Trends and Growth – News by aeresearch

Tuesday, December 3rd, 2019

New Report on Absorbable and Non-Absorbable Sutures Market size | Industry Segment by Applications (Cardiovascular, Orthopedic, Gynecology, Opthalmology, General Surgery and Others), by Type (Absorbable Sutures and Non-Absorbable Sutures), Regional Outlook, Market Demand, Latest Trends, Absorbable and Non-Absorbable Sutures Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025. Analyzes current market size and upcoming 5 years growth of this industry.

A comprehensive analysis of the Absorbable and Non-Absorbable Sutures market is presented in this document, along with a brief overview of the segments in the industry. The study presents a feasible estimate of the current market scenario, including the Absorbable and Non-Absorbable Sutures market size with regards to the volume and renumeration. The report is a collection of significant data related to the competitive landscape of the industry. It also contains data with regards to several regions that have successfully established its position in the Absorbable and Non-Absorbable Suturesmarket.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/1271

Repot Scope:

Absorbable and Non-Absorbable Sutures Market Outlook by Applications:

Absorbable and Non-Absorbable Sutures Market Statistics by Types:

Absorbable and Non-Absorbable Sutures market competition by top Manufacturers:

A Glimpse over the highlights of the report:

Providing a thorough outline of the competitive and regional spheres of the Absorbable and Non-Absorbable Sutures market:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/1271

Read this article:
Absorbable and Non-Absorbable Sutures Market Research, Recent Trends and Growth - News by aeresearch

Read More...

Ambulatory Healthcare IT Market Syndicated Research, Industrial Analysis With AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway…

Sunday, November 17th, 2019

The Ambulatory Healthcare IT market report contains thorough description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis and porters five force analysis. This report gives an actionable market insight to the clients with which they can create sustainable and profitable business strategies. This market research report is an absolute outline of the global industry which is penned down so that an unskilled individual as well as professional can easily extrapolate the entire Ambulatory Healthcare IT market within a few seconds. According to this market report, new highs will take place in the Ambulatory Healthcare IT market in 2019 2026.

Ambulatory Healthcare IT Market report has been crafted carefully to provide the latest insights into the significant aspects of the Market. This Ambulatory Healthcare IT Market research report is the exhaustive analysis of the market across the world. It offers an overview of the market including its definition, key drivers, key market players and key segments. In addition, the study presents statistical data on the status of the market and hence is a valuable source of guidance for companies and individuals interested in the Industry. Market segmentations break down the key sub sectors which make up the market.

Download Sample Report With All Graphs & Charts (Updated Values Are Listed In Sample Report): https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ambulatory-healthcare-market

Ambulatory care is also referred as outpatient care. It is a medical care given on outpatient criteria such as consultation, rehabilitation, observation, intervention, diagnosis, and treatment services. Ambulatory care involves emergency care, primary care, ambulatory services, and others. In this intervention and surgery, overnight hospital stay is not required.

The report highly involves chapter wise explanation for every aspect of the market wherein the drivers, trends, opportunities, leading and trending segments are discussed in detail with specific examples. Profiles of leading players are also discussed along with their business expansion strategies.

Few of the major market competitors currently working in the global ambulatory healthcare IT market are AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway Medical Group, SurgCenter, Trillium Health Partners, Medical Facilities Corporation, Nueterra Capital, Aspen Healthcare, Suomen Terveystalo Oy, IntegraMed America, Inc., SHERIDAN HEALTHCARE, NueHealth, Athenahealth, GENERAL ELECTRIC, Optum, Inc., Apria Healthcare Group, Inc., DaVita Inc., LVL Medical, Fresenius Kabi AG, Sonic Healthcare among others.

Get TOC To Analyze Major Sections Of The Ambulatory Healthcare IT Market Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-ambulatory-healthcare-market

The predictions featured in this report have been derived using proven research methods and standards. With this data, the research report serves as a source of information and analysis for every segment of the market, including but not restricted to: local markets, product, and application.

Global Ambulatory Healthcare IT Market By Type (Ambulatory Services, Primary Care Offices, Outpatient Departments, Emergency Departments, Surgical Specialty, Medical Specialty, Others), Modality (Hospital-affiliated, Freestanding), Surgery Type (Opthalmology, Orthopedics, Gastroenterology, Pain Management, Others), Application (Laceration Treatment, Bone Fracture Treatment, Emergency Care Service, Trauma Treatment)

Based on the geography

North America

South America

Asia and Pacific region

Middle east and Africa

Europe

Have look on the Premium Insights of the Report

The report covers 360-degree view of the market that encompasses statistical forecast, competitive landscape, all-inclusive segmentation and Strategic Suggestions

It provides in depth analysis by type, end user and regions.

Pricing analysis, Regulatory factor analysis and value chain analysis are mentioned in the report

In the end, this Ambulatory Healthcare IT Market report gives all the required to help to strive the business successfully.

Want Full Report? Enquire Here: https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-ambulatory-healthcare-market

About Us

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing Corporatesales@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475Mail:Corporatesales@databridgemarketresearch.comhttps://databridgemarketresearch.com

More here:
Ambulatory Healthcare IT Market Syndicated Research, Industrial Analysis With AmSurg Corp, Surgical Care Affiliates, Surgery Partners, Healthway...

Read More...

Shades of corruption in Nigeria – New Telegraph Newspaper

Thursday, October 31st, 2019

As an aside to this article, reference is made to an ongoing global promo for the nomination of persons as Anti-Corruption Heroes of 2019, for the Sheikh Tamim Bin Hamad Al Thani International Anti-Corruption Excellence (ACE) Award.

The promo features the December 2018 presentation of the award to Mr. Nuhu Ribadu, the pioneer Executive Chairman of the Economic and Financial Crimes Commission (EFCC).

The high-point of the ceremony, held in Putrajaya, Malaysia, was not in the presentation with the plaque, but in the introduction of Ribadu as a man who refused a $15 million bribe.

That case involved a former Nigerian governor, who the EFCC, under Ribadu, was investigating over a monumental fraud in his eight-year rule of his state.

To possibly kill the investigation, the suspect offered Ribadu a $15 million bribe, but he turned it down, and deposited the hefty sum with the Central Bank of Nigeria (CBN), as a potential exhibit.

Sadly, the invitation for nomination for the 2019 ACE Award coincides with fresh attempts to ease Ibrahim Magu from the EFCC, where hes been Acting Chairman since November 2015.

Thus, the Ribadu anecdote serves to refresh our memory that, save the coming of Magu, the anti-corruption war thats at its nadir when he took over would have long been dead, and forgotten.

The EFCC, as the toughest job in the polity, is the single body that shines the light in the dark places where corruption and the corrupt cohabit to undermine the citizens patrimony.

Shining that light to expose their cohabitation is an arduous and risky task, demanding only the strong-willed to superintend. As the maxim goes, If you fight corruption, corruption will fight back.

And corruption in Nigeria is fighting back, with the non-confirmation of Magu aimed at stopping the crusade from uprooting corruption or reducing the scourge in the system.

The Senate of the Eighth National Assembly, conniving with outside forces located mainly in the government at national and sub-national levels, frustrated the confirmation of Magu.

The Senate, hiding behind unfavourable security reports by the Department of State Services (DSS), declined to confirm him twice, and yet pressured President Muhammadu Buhari to sack him.

Can the Director of the DSS, an aide, be more concerned about the screening than President Buhari, who nominated Magu twice despite the so-called unfavourable security reports?

If the rules were/are followed, Magu would be substantive Chairman of the EFCC, as the 1999 Constitution (as amended) does not envisage him to get approval of the Senate.

Section 171(1) of the Constitution provides that: Power to appoint persons to hold or act in the offices to which this section applies, and to remove persons so appointed from any such office, shall vest in the President.

Section 171(2)(a-e) states the offices to which this section applies, while subsection (d) designates the office as the Permanent Secretary in any Ministry or Head of any Extra-Ministerial Department of the Government of the Federation howsoever designated.

Does section 171(1)(2)(d) apply to Ibrahim Magu, who heads an Extra-Ministerial Department of the Government of the Federation in the EFCC?

Absolutely, argues Kabir G. Ibrahim, a legal practitioner and anti-corruption activist, who, in an article published by several websites in March 2017, dealt with the constitutional, statutory and judicial position of the law regarding the Magu saga.

He said: Flowing from the above constitutional provision, it is safe to posit that once the President appoints a person as Chairman of the EFCC, such person does not require the confirmation of the Senate

Citing the position of the law, as decided by Ayoola JSC (as he then was) in a case, I.N.E.C. v. Musa (2003) 3 NWLR (Pt. 806) 72 at 158 and 199, Mr. Ibrahim contends that in covering the field, the National Assembly cannot arrogate to itself powers that impeach the Constitution.

The Supreme Court ruling: Howsoever it is described, where the Constitution has covered the field as to the law governing any conduct, the provision of the Constitution is the authoritative statement of the law on the subject.

The supremacy of the National Assembly is subject to the overall supremacy of the Constitution. Accordingly, the National Assembly which the Constitution vests powers cannot go outside or beyond the Constitution

Why is Magu the sustained scorn of the lootelite (elite looters)? Because he remains the only pain in their butt. Their fear is his reiteration in January 2019 that the EFCC would secure more convictions than it did in 2018 when it got 312 convictions.

The records are not yet out, but another reason for wanting him out is what many Nigerians didnt know: Magu is one of the backbones of the acclaimed successes of the Ribadu era at the EFCC.

Hes described as a tougher cop than Ribadu. Hes patient, and interrogates suspects non-stop for hours, to wear them down. So, they would prefer to be quizzed by other interrogators.

Heres to show Magus toughness, as a lawyer told TheCable. Ribadu had asked him to release someone from detention and ask him to come back. But Magu, while saluting Ribadu, said, We shall release him, Sir, after he has answered our questions.'

Magu is about the longest top serving investigator in the EFCC, possessing a trove of dossiers on politically-exposed persons (PEPs), including, perhaps, the 23 completed case files of the 31 governors that Ribadu said were under investigation in 2006.

Hence, those who want him out are former and serving governors, lawmakers, ministers and heads of ministries, departments and agencies (MDAs); alleged cabals in the Presidency; and financial suckers in the private sector. So, as currently constituted, remove Magu from the EFCC, and these manipulators of the system for individual and group interests would have a field day stealing the nation blind.

Rather than answer to their charges, they parrot being witch-hunted. But Magu seems deaf to such nuances, focusing on the political determination, and exhortation of President Buhari that, If we do not kill corruption, corruption will kill us.

And Magus message: My dream is to leave a better Nigeria, free of corruption to the next generation. We cannot continue the way we are going; otherwise, there will be no Nigeria for the next generation.

Will his traducers allow him to achieve this self-imposed dream he vows to pursue with his last breath? Well, only President Buhari can determine that by renewing his mandate at the EFCC.

International convention forbids Magus removal midway into his tenure as Chairman of the Commonwealth Conference of Heads of Anti-Corruption Agencies in Africa. Doing so could also dent the image of Buhari as coordinator of Africas anti-corruption war.

Like Loading...

Related

Advertisements

Read the rest here:
Shades of corruption in Nigeria - New Telegraph Newspaper

Read More...

Highlights from Day Two of the World Congress of Neurology 2019 – WFN News

Wednesday, October 30th, 2019

Report byProf. Tissa Wijeratne MD FRACP FRCP (Edin) FRCP (London) FAHA FAAN (USA)

An exciting second day in Dubai started at 7.00 am with a masterclass in Neuro-Opthalmology. It was attended by a packed audience presented with an interestingassortment of cases by Dr Gordon Plant and Dr Vivek Laal.

The Plenary lecture on Reading in the Brain: Mapping the massive impact of literacy on brain circuits" was delivered by Prof. Stanislas Dehaene.

Dr Adrian Owen delivered the second plenary lecture on The Gray Zone and Brain Death."

Professor Russel Foster delivered the Soriano award lecture on light, circadian rhythms and sleep, mechanisms to new therapeutics. The first part of this brilliant lecture considered the discovery and clinical importance of the third photoreceptor system of the eye. The second part of the talk went on to discuss the connection between photoreceptor signal light, clockwork and sleep. He went on to discuss the detailed molecular changes during the circadian rhythm.

Dr Tedros, Director-General, World Health Organisation,delivered a video message on the WHO and recent collaborative outcomes.

Professor Raad Shakir, Immediate past president, WFN delivered the important news on ICD-11 and its impact on the future of neurology.

Professor William Carroll, President WFN delivered a lecture on the global role of World Federation of Neurology. Professor Bo Norrving delivered the much-awaited news on the implications of the reclassification of stroke as a neurological disease.

The WFN- Young neurologists, trainees and medical students informal gathering was a great success. Professor Tissa Wijeratne moderated the discussion. There was active participation. WFN trustees and the high-level leadership was available for the discussion and future of this group looks promising.

The number of parallel sessions covering dementia, headache disorders, movement disorders, MS and demyelinating disorders, dementia, neurooncology, advocacy, stroke medicine were highly successful.

The rest is here:
Highlights from Day Two of the World Congress of Neurology 2019 - WFN News

Read More...

Global Active Pharmaceutical Ingredient Market Future 2019-2028 Including Threats, Futuristic Trends, Share, Size and Growth Opportunities – TheLoop21

Wednesday, October 30th, 2019

New York City, NY: October 29, 2019 Published via (WiredRelease) Global (United States, European Union and China) Active Pharmaceutical Ingredient Market Research Report 2019-2028. The MarketResearch.biz analyses the report based on customer demand, supply and demand status, competitive market scenario and industry policies. The Active Pharmaceutical Ingredient Market report covers all the minute details related to the industry like Technological Developments, Growth Opportunities, Threats to Market Growth, Innovative Strategies and Futuristic Market Trends.

Active Pharmaceutical Ingredient market report provides a comprehensive overview of current trends and new product development in the global Active Pharmaceutical Ingredient market. Featuring global and regional data and over top key players profiles, this report provides the ultimate guide to exploring opportunities in the keyword industry internationally. Some of the key players in the market are, Aurobindo Pharma, Sanofi, Cipla Limited, GlaxoSmithKline plc, Lupin Limited, Merck & Co., Mylan N.V., Teva Pharmaceutical Industries Ltd, Novartis Pharmaceuticals Corporation and Ipca Laboratories Ltd.

Download Free Sample Copy of Active Pharmaceutical Ingredient Market Report Study 2019-2028 At:https://marketresearch.biz/report/active-pharmaceutical-ingredient-market/request-sample

In this study, 2018 has been considered as the base year and 2019 to 2028 as the forecast period to estimate the market size for Active Pharmaceutical Ingredient. This report researches the worldwide Active Pharmaceutical Ingredient market size (capacity, value, production and consumption) in key regions like Europe, United States, Asia Pacific (Japan, China),Middle & Africaand other regions.

Active Pharmaceutical Ingredient Market Report Includes:

Industry Trends:Status and Outlook.

Product Revenue for Top Players: Growth Rate, Market Share, Current Market Situation Analysis.

Market Segment:manufacturing process, API type, drug type, therapeutic area, and region

Competitive Landscape: By Manufacturers, Development Trends.

Sales Revenue: Growth Rate, Market Share, Current Market Analysis.

Segments ofActive Pharmaceutical Ingredient Market:

Segmentation by Manufacturing Process: Captive Manufacturing, Contract Manufacturing. Segmentation by API Type: Synthetic API, Biological API. Segmentation by Drug Type: Prescription Drugs, Over-The-Counter Drugs. Segmentation by Therapeutic Area: Communicable Diseases, Oncology, Opthalmology, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Other

Benefits of Purchasing Active Pharmaceutical Ingredient Market Report:

Analyst Support:Get your query resolved from our expert analysts before and after purchasing the report.

Customers Satisfaction: Our expert team will assist with all your research needs and customize the report.

Inimitable Expertise: Analysts will provide in-depth insights of the market.

Assured Quality: We focus on the quality and accuracy of the report.

Some key points of Global Active Pharmaceutical Ingredient Market research report:

Strategic Developments: The custom analysis gives the key strategic developments of the market, comprising R&D, new product launch, growth rate, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Market Features: The report comprises market features, capacity, capacity utilization rate, revenue, price, gross, production, production rate, consumption, import, export, supply, demand, cost, market share, CAGR, and gross margin. In addition, the report offers a comprehensive study of the market dynamics and their latest trends, along with market segments and sub-segments.

Analytical Tools: The Global Active Pharmaceutical Ingredient Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, feasibility study, and many other market research tools have been used to analyze the growth of the key players operating in the market.

Customize Report AndInquiry For The Active Pharmaceutical Ingredient Market Report:https://marketresearch.biz/report/active-pharmaceutical-ingredient-market/#inquiry

Research objectives of Active Pharmaceutical Ingredient Market:

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Conclusively, This report will provide you a clear view of each and every fact of the market without a need to refer to any other research report or a data source. Our report will provide you with all the facts about the past, present, and future of the concerned Market.

ABOUT US:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. The company offers services such as data mining, information management, and revenue enhancement solutions and suggestions. We cater to industries, individuals, and organizations across the globe, and deliver our offerings in the shortest possible turnaround time.

Contact Us At

Mr. Benni Johnson

MarketResearch.Biz (Powered By Prudour Pvt. Ltd.)

420 Lexington Avenue, Suite 300

New York City, NY 10170,

United States

Tel: +1 347 826 1876

Website:https://marketresearch.biz

Email ID:[emailprotected]

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at[emailprotected].

More:
Global Active Pharmaceutical Ingredient Market Future 2019-2028 Including Threats, Futuristic Trends, Share, Size and Growth Opportunities - TheLoop21

Read More...

New Study Adds Concern That Medication To Treat Painful Bladder Condition Linked To Vision-Threatening Eye Condition – Forbes

Friday, October 18th, 2019

Age-related macular degeneration with neovascularization of torn and rolled-up retinal pigmented ... [+] epithelium. (Photo By BSIP/UIG Via Getty Images)

Evidence continues to mount that a drug commonly prescribed for decades to treat a painful bladder condition known as interstitial cystitis (IC) is linked to retinal damage and toxicity. The retina is the light-sensing tissue at the back of the eye that allows us to see our world.

A 2018 study by Nieraj Jain, M.D, Assistant Professor of Ophthalmology, Emory University School of Medicine, Emory Eye Center, reported reading difficulty and visual changesespecially under dark conditionsamong six patients who had been taking the drug, Elmiron (pentosan polysulfate sodium, PPS) for an average of 15 years (range of 12-20 years).

Jain found that this group of six patients (median age 60; age range 37-62) all had atypical changes in their macula, the central part of the retina that allows us to have clear central vision. The patients described difficulty reading in dim light and diminished central visual acuity. The patients underwent genetic testing to determine if there was any basis for hereditary retinal loss, with none demonstrating any such evidence of a link. Other than Elmiron, there was no clear etiology based on other findings in their medical history that explained the concerning retinal changes found in all six patients. This led the researchers to issue a warning in 2018 that long-term use of Elmiron could potentially lead to retinal damage.

An additional 10 patientsage range of 38-68 years of agewith similar retinal changes were also reported by the same researchers in May of 2019, and presented at the 2019 annual meeting of the American Urological Association. The authors concluded that structural changes in the retina were certainly present, stating that it was unclear if stopping the medication would reverse the noted changes.

This ongoing concern led researchers from Kaiser Permanente in Northern California to study this phenomenon further in their own patients taking this medication.

They found that about 25% of their patients with significant exposure to Elmiron showed clear evidence of retinal damage. The concern is that toxicity from this medication could also appear to mimic other well-known retinal conditions, such as age-related macular degeneration (AMD) or an uncommon retinal condition known as pattern dystrophy.

The research was presented last week at AAO 2019, the 123nd Annual Meeting of the American Academy of Ophthalmology.

Interstitial cystitis (IC) is a cause of unrelenting pain in the bladder and pelvic regions of the lower abdomen. Its estimated that at least 1 million people, mostly women, in the U.S. have thispainful condition. While other pharmacologic (NSAIDS, antihistamines, bladder installation therapy) and behavioral approaches are available, Elmiron is the only FDA-approved medication to treat this painful and disabling condition. It effectively works by forming a protective coating on the inner lining of the bladder that reduces irritation by substances present in the urine. Since its a first-line drug used for many decades, its believed that at least several hundred of thousand people have likely been exposed to the drug.

Robin A. Vora, M.D., Consultant in Medical Retina, Chair of Ophthalmology, Kaiser Permanente, Northern California and colleagues (Amar Patel, M.D., and Ronald Melles, M.D.) described a woman on long-term Elmiron who was misdiagnosed as having a retinal dystrophy, a genetic cause of progressive vision loss that may lead to permanent blindness. As a result of their concern that more patients that could be affected, they decided to evaluate all 4.3 million Kaiser patients.

Searching the database, they identified 140 patients who had each taken an average of 5,000 pills over a period of 15 years. Ninety-one patients of the 140 were evaluated. The investigators captured retinal images and rated them as normal, possible abnormality, or definite abnormality. The toxicity involved specialized cells known as retinal pigmented epithelium (RPE) that help nourish precious vision-producing cells in the retina known as the macula. Twenty-two of the 91 patients showed clear signs of drug toxicity. The rate of toxicity increased with the amount of drug taken, from 11% of those taking 500 to 1,000 grams to 42% of those taking 1,500 grams or more.

Its unfortunate, said Vora. You have a patient with a chronic condition like interstitial cystitis, for which there is no cure and no effective treatment. They get put on these medications because its thought to have few side effects and few risks, and no one thinks about it again year after year, the number of pills theyre taking goes up and up.

Since there is no comprehensive data yet available to guide treatment, Vora recommends patients who are asymptomatic and show no retinal signs of toxicity be screened for retinal damage at least annually. Patients who are showing signs of toxicity need to have a conversation with their health care provider whether to stop taking the medication.

Urologists and gynecologists are the primary medical providers for patients with IC. Elizabeth Kavaler, M.D., a urologist with Lenox Hill Hospital in New York City, suggested active retinal surveillance of patients would be prudent in managing patients with IC.

The impact of IC on the life of people who suffer with it cannot be minimized, she said. For women who have had good success with Elmiron, and are able to live their lives without chronic, unremitting pain, perhaps yearly or biyearly retinal exams should be done.

The mechanism behind the toxicity is unclear, but may involve the production of a toxic metabolite of Elmiron. Jains team has suggested that a component of Elmiron, a glycosaminoglycan (GAG) with a highly negative charge, may also play a potential role in disrupting the interphotoreceptor matrix in the macula. Other research by Singh and colleagues from Cleveland Clinic has suggested that Elmiron acts as an antagonist of signaling pathways related to fibroblast growth factor (FGF), a protein integral to retinal maintenance and function. There is no research that has yet elucidated the exact mechanism.

Jain has been in contact with the FDA, which is aware of his and other research linking Elmiron to retinal damage. To date, the FDA has not taken any action or issued any alerts regarding the toxicity of the medication.

The researchers are expressing growing concern that the presentation of these patients is unique and does not resemble any other identified acquired or hereditary maculopathy. At this time, an association or link with PPS exposure and maculopathy exists, but no definitive cause and effect relationship. The broader question is whether visual problems may be an unrecognized effect of IC; there have been no studies to link these two conditions as of yet.

If the changes are picked up early, its unclear whether retinal damage is reversible by discontinuing the medication. Long term monitoring will be required to make this clinical determination. For those with no clear evidence of damage who are currently taking the medication, close monitoring is critical, according to Vora and Jain. However, in later stages, toxicity can resemble late-stage dry atrophic age-related macular degeneration (AMD) and result in permanent vision loss.

Here is the original post:
New Study Adds Concern That Medication To Treat Painful Bladder Condition Linked To Vision-Threatening Eye Condition - Forbes

Read More...

Page 8«..78910..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick